Literature DB >> 23787705

Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism.

Pablo Quintero1, Marco Arrese.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23787705     DOI： 10.1002/hep.26582

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

Review 1.  Pharmacotherapy for Nonalcoholic Fatty Liver Disease.

Authors:  Samer Gawrieh; Naga Chalasani
Journal:  Semin Liver Dis       Date:  2015-09-17       Impact factor: 6.115

2.  Palmitoleic acid (n-7) attenuates the immunometabolic disturbances caused by a high-fat diet independently of PPARα.

Authors:  Camila O Souza; Alexandre A S Teixeira; Edson A Lima; Helena A P Batatinha; Lara M Gomes; Milena Carvalho-Silva; Isabella T Mota; Emilio L Streck; Sandro M Hirabara; José C Rosa Neto
Journal:  Mediators Inflamm       Date:  2014-07-24       Impact factor: 4.711

3.  Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis.

Authors:  Tea Omanovic Kolaric; Tomislav Kizivat; Vjera Mihaljevic; Milorad Zjalic; Ines Bilic-Curcic; Lucija Kuna; Robert Smolic; Aleksandar Vcev; George Y Wu; Martina Smolic
Journal:  Curr Issues Mol Biol       Date:  2022-08-02       Impact factor: 2.976

Review 4.  The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis.

Authors:  Jingjing Li; Chuanyong Guo; Jianye Wu
Journal:  Drug Des Devel Ther       Date:  2021-06-18       Impact factor: 4.162
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.